XingImaging
Highly Engaged Employees
Highly Engaged EmployeesHealthcare Services · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
55 Church St Fl 7, New Haven, Connecticu...Website
www.xingimaging.comRevenue
<$5 MillionIndustry
ZI Rank: 3
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
3
2
7
3
About XingImaging
XingImaging, LLC is a neuroimaging services company that specializes in the application of scintigraphic biomarkers for drug development and clinical research focused on neurodegenerative and neuropsychiatric disorders. The company operates a state-of-the-art research facility in New Haven, Connecticut, and offers a range of services including radioligand development, clinical trial design, and imaging site management. With a dedicated team organized into various divisions, XingImaging emphasizes research using investigational radiotracers and quantitative imaging for diagnostic purposes. Their expertise contributes to advancing knowledge and treatments in clinical neuroscience and nuclear medicine.Explore more
Popular SearchesXingImaging LLCSIC Code 80,807NAICS Code 62,621Show moreXingImaging Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is XingImaging your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if XingImaging had a recent Job posting/layoffs
XingImaging, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on XingImaging recently announced quarterly report
Check out if XingImaging is spiking on competitors!
Product Launch: Get notified when XingImaging launches new products
Congratulate Masked Content for being promoted to Masked Content at XingImaging
Funding: Get notified immidiatlly once XingImaging has new funding data
Check if XingImaging has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to XingImaging
Compare insights from companies similar to XingImaging, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
XingImaging is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
XingImaging is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about XingImaging.
XingImaging Tech Stack
A closer look at the technologies used by XingImaging
XingImaging News & Media
SynuSight Biotech, ABLi Therapeutics and XingImaging Announce Strategic Collaboration to Implement Alpha-Synuclein PET Imaging into Clinical Trials Evaluating Risvodetinib as a Disease-modifying Therapy for Parkinson's disease
SynuSight Biotech has licensed 18F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment SHANGHAI, ATLANTA and NEW HAVEN, Conn. , Jan. 5, 2026 /PRNewswire/ -- SynuSight Biotech ("SynuSight"), a biotechnology...New Haven firm, Chinese biotech share $3.8M grant for Parkinson's research
New Haven-based neuroimaging company XingImaging and a Chinese biotech firm have received a $3.84 million grant from The Michael J. Fox Foundation to advance research on a brain imaging tool that could help diagnose Parkinson’s disease earlier.XingImaging in partnership with SynuSight was awarded a grant from The Michael J. Fox Foundation to support development of the α-synuclein PET tracer 18F-FD4 for Parkinson's disease
NEW HAVEN, Conn., Sept. 10, 2025 /PRNewswire/ -- XingImaging in partnership with SynuSight Biotech has received funding of $3.84M from The Michael J. Fox Foundation to conduct studies on 18F-FD4, a specific α-synuclein (α-syn)-targeted PET tracer. Based on prior investigator-initiated...XingImaging Unveils NX PET Camera to Advance Parkinson's Disease Research
NEW HAVEN, Conn., April 30, 2025 /PRNewswire/ -- XingImaging, a MITRO company, a pioneer in advanced research imaging, radiopharmaceutical services, and medical imaging technology, proudly announces the launch of the **NX PET Camera**, a breakthrough in positron emission tomography (PET)...
Read more news
Top Healthcare Services Companies
Frequently Asked Questions Regarding XingImaging
Sign Up For FreeTo access detailed company insights
XingImaging, LLC is a neuroimaging services company that specializes in the application of scintigraphic biomarkers for drug development and clinical research focused on neurodegenerative and neuropsychiatric disorders. The company operates a state-of-the-art research facility in New Haven, Connecticut, and offers a range of services including radi... Read More
